Grifols Usa
UEI: D48FNWJCJ5H5
• CAGE: 1N5P5
Overview
Parent Awardee
Company Description
Grifols, global healthcare leader in producing plasma derived medicines and other innovative biopharmaceutical solutions, is dedicated to improving the health and well-being of patients.
Name
Grifols Usa
Website
Headquarters
Los Angeles, CA
United States
United States
Most Recent Award
Oct. 1, 2025
Calculating
Grifols Usa is a federal contract recipient (UEI D48FNWJCJ5H5; CAGE 1N5P5). It has also received state and local contract awards. It is headquartered in Los Angeles, CA. Its primary registered NAICS is 325412: Pharmaceutical Preparation Manufacturing. The corporation was founded in August 1995 and federally registered in July 2026.
Federal Award Analysis
Grifols Usa federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GRIFOLS USA LLC
UEI
D48FNWJCJ5H5
CAGE Code
1N5P5
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 2, 1995
Initial Registration
July 23, 2026
Last Registration
July 24, 2026
Registration Activation
July 24, 2026
Registration Expiration
July 23, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Manufacturer of Goods
Limited Liability Company
Manufacturer of Goods
State of Incorporation
FL
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Grifols Usa
GSA Schedules and Price Lists
- Grifols Usa
- PoP: 4/30/22 - 4/30/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $2,533,923